Summary
A female patient is described in whom the diagnosis of idiopathic hypereosinophilic syndrome (HES) with heart disease and peripheral neuropathy was made at the age of 32 years. Although prednisone induced a prompt and longstanding complete hematological remission, progressive and eventually intractable heart failure developed, and the patient died 6 years later. Endomyocardial biopsy at diagnosis showed infiltration with intact and disintegrated eosinophils and Charcot-Leyden crystals. Echocardiographic follow-up (including Doppler-Echocardiography) revealed mitral regurgitation with thickening and impaired motility of the posterior mitral leaflet, as well as progressive dilated cardiomyopathy. At autopsy, a diffuse interstitial fibrosis with patchy prominence in an eccentric hypertrophic and highly dilated heart was found. There were no significant endocardial thickening and no mural thrombi. In contrast to the findings of the initial endomyocardial biopsy, autopsy revealed no eosinophilic infiltrate.
In this case, eosinophil-induced heart disease manifested as dilated cardiomyopathy, without endocardial fibrosis as originally described by Löffler. We speculate, that eosinophils have been deposited predominantly in the myocard at an early stage of disease, and — activated locally — secreted their granule proteins producing an initial damage to capillary endothelial cells and myocytes. After prednisone-induced clearance of eosinophils from blood and tissues, progressive, self-perpetuating interstitial fibrosis of the myocard and loss of myocytes eventually resulted in end-stage dilated cardiomyopathy.
Similar content being viewed by others
Abbreviations
- HES:
-
idiopathic hypereosinophilic syndrome
- UBBC:
-
unsaturated vitamin B12 binding capacity
- ECP:
-
eosinophil cationic protein
- MBC:
-
major basic protein
- EDD:
-
end-diastolic diameter of the left ventricle
- LA:
-
left atrium diameter
- LVEDP:
-
left ventricular end-diastolic pressure
- NIH:
-
National Institutes of Health
References
Adrouny A, Seraydarian A, Levine AM, Hungerford GF, Carmel R (1984) Cyclic eosinophilic leukocytosis in eosinophilic leukemia with observations on transcobalamin I and eosinophils. Cancer 54:1374–1378
Barnhart MI, Riddle JM (1963) Cellular localization of profbrinolysin (plasminogen). Blood 21:306–321
Chiusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine 54:1–27
Dahl RA, Venge P (1979) Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes. Thromb Res 4:599–609
Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH (1982) NIH conference: the idiopathic hypereosinophilic syndrome. Ann Intern Med 97:78–92
Ghosh K, Shome DK, Marwaha N, Mhanty D, Das KS (1984) Normal levels of B12 binding proteins in hypereosinophilic syndrome and secondary hypereosinophilia. Blood 63:510
Gleich GJ, Loegering DA, Maldonado JE (1973) Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med 137:1459–1471
Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller L (1979) Cytotoxic properties of the eosinophil major basic protein. J Immunol 123:2925–2927
Gleich GJ, Loegering DA, Frigas E, Wassom DL, Solley GO, Mann KG (1980) The major basic protein of the eosinophil granule: Physiochemical properties, localization, and function. In: Mahmoud AAF, Austin KF, eds. The Eosinophil in Health and Disease. Grune & Stratton, New York, pp 79–97
Lisiewicz J, Okulski J (1970) Thromboplastic activity of leukemic eosinophils. Haematologica (Budapest) 4:213–220
Löffler W (1936) Endocarditis parietalis fibroplastica mit Bluteosinophilie. Ein eigenartiges Krankheitsbild. Schweiz Med Wochenschr 66:817–820
Olson EG, Spry CJ (1985) Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis 27:241–254
Parillo JE, Fauci AS, Wolff SM (1978) Therapy of the hypereosinophilic syndrome. Ann Intern Med 89:167–172
Parillo JE, Borer JS, Henry WL, Wolff SM, Fauci AS (1979) The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective Study of 26 patients, with review of the literature. Am J Med 67:572–582
Riddle JM, Barnhart MI (1965) The eosinophil as a source of profibrinolysin in acute inflammation. Blood 25:776–794
Solley GO, Maldonado JE, Gleich GJ, Giuliani ER, Hoagland HC, Pierre RV, Brown AL (1979) Endomyocardiopathy with eosinophilia. Mayo Clin Proc. 51:697–707
Spry CFJ, Tai PC (1976) Studies on blood eosinophils. II. Patients with Loeffler's cardiomyopathy. Clin Exp Immunol 24:423–434
Tai PC, Hayes DJ, Clark JB, Spry CJ (1982) Toxic effects of human eosinophil products on isolated rat heart cells in vitro. Biochem J 204:75–80
Tai PC, Spry CJ, Olson EG, Ackermann SJ, Dunnette S, Gleich GJ (1987) Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1:643–647
Venge P, Dahl R, Hallgren R (1979) Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res 14:641–649
Wassom DL, Loegering DA, Solley GO et al. (1981) Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest 67:651–661
Wautier JL, Souchon H, Dupuis D, Caen JP, Nurden AT (1979) A platelet defect in a patient with eosinophilic leukaemia: absent ristocetin-induced platelet aggregation associated with a reduced platelet sialic acid content. Scand J Haematol 22:267–276
Zittoun J, Farcet JP, Marquet J, Sultan C, Zittoun R (1984) Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. Blood 63:779–783
Zoller VH (1973) Blutgerinnungsstörung bei einer chronischen Eosinophilen-Leukämie. Münch Med Wochenschr 115:1036–1038
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Christen, R., Morant, R., Schneider, J. et al. Progressive dilated cardiomyopathy in a patient with longstanding and complete prednisone-induced hematological remission of idiopathic hypereosinophilic syndrome. Klin Wochenschr 67, 358–365 (1989). https://doi.org/10.1007/BF01741392
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741392